UCB SA (UCBJY)
64.25
-0.78
(-1.20%)
USD |
OTCM |
May 09, 15:59
UCB Price: 64.25 for May 9, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 08, 2024 | 65.21 | 65.31 | 64.92 | 65.03 | 28483.00 |
May 07, 2024 | 64.96 | 64.96 | 64.40 | 64.43 | 23619.00 |
May 06, 2024 | 64.47 | 64.49 | 64.22 | 64.49 | 61115.00 |
May 03, 2024 | 65.23 | 65.26 | 64.78 | 64.86 | 5447.00 |
May 02, 2024 | 64.94 | 65.57 | 64.86 | 65.57 | 18593.00 |
May 01, 2024 | 66.60 | 66.98 | 66.30 | 66.66 | 6552.00 |
Apr 30, 2024 | 66.50 | 66.78 | 66.23 | 66.23 | 6280.00 |
Apr 29, 2024 | 66.13 | 66.28 | 66.00 | 66.06 | 6441.00 |
Apr 26, 2024 | 66.23 | 66.63 | 66.23 | 66.48 | 36784.00 |
Apr 25, 2024 | 66.06 | 67.30 | 66.06 | 67.30 | 32760.00 |
Apr 24, 2024 | 64.46 | 64.79 | 64.46 | 64.79 | 3425.00 |
Apr 23, 2024 | 65.53 | 65.53 | 65.06 | 65.26 | 5933.00 |
Apr 22, 2024 | 65.55 | 65.55 | 64.93 | 64.93 | 6171.00 |
Apr 19, 2024 | 64.52 | 64.86 | 64.31 | 64.54 | 3535.00 |
Apr 18, 2024 | 64.38 | 64.46 | 63.63 | 63.68 | 7177.00 |
Apr 17, 2024 | 62.95 | 64.18 | 62.91 | 64.07 | 71706.00 |
Apr 16, 2024 | 63.00 | 63.59 | 62.90 | 63.31 | 9417.00 |
Apr 15, 2024 | 63.17 | 63.64 | 62.83 | 63.00 | 10776.00 |
Apr 12, 2024 | 64.94 | 65.00 | 63.87 | 63.87 | 11298.00 |
Apr 11, 2024 | 62.17 | 63.24 | 62.17 | 63.06 | 8494.00 |
Apr 10, 2024 | 61.61 | 61.94 | 61.59 | 61.94 | 10455.00 |
Apr 09, 2024 | 62.16 | 62.16 | 61.74 | 61.79 | 4597.00 |
Apr 08, 2024 | 61.91 | 62.14 | 61.88 | 62.14 | 4103.00 |
Apr 05, 2024 | 63.00 | 63.00 | 61.74 | 61.81 | 9178.00 |
Apr 04, 2024 | 63.14 | 63.15 | 62.25 | 62.25 | 9858.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
32.45
Minimum
Mar 18 2020
68.00
Maximum
Jul 30 2020
47.51
Average
46.33
Median
May 12 2021
Price Benchmarks
Galapagos NV | 28.77 |
Mithra Pharmaceuticals SA | 6.75 |
Nyxoah SA | 8.79 |
Celyad Oncology SA | 0.315 |
MDxHealth SA | 2.86 |
Price Related Metrics
PE Ratio | 67.03 |
PS Ratio | 4.407 |
Price to Book Value | 2.458 |
Price to Free Cash Flow | 52.20 |
Earnings Yield | 1.49% |
Market Cap | 24.39B |
Operating PE Ratio | 36.44 |
Normalized PE Ratio | 67.34 |